SAMHSA’s Coronavirus resources

Community-based efforts Data and Information News Public Health Research Resource SAMHSA

Resources

In response to the COVID-19 pandemic, SAMHSA is offering several resources for mental and substance use disorder treatment providers and others. In addition, given the rapidly evolving situation with COVID-19, SAMHSA is providing regular updates via a new consolidated COVID-19 page. This page can be found at samhsa.gov/coronavirus. Please check for new updates.

COVID-19 Guidance for Opioid Treatment Programs

SAMHSA is offering guidance on pharmacotherapy for opioid use disorder availability in circumstances in which patients may be exposed to highly contagious infectious agents (such as COVID-19).

FAQs: Provision of Methadone and Buprenorphine for the Treatment of Opioid Use Disorder in the COVID-19 Emergency

In response to the Coronavirus Disease (COVID-19) pandemic, SAMHSA is providing answers to Frequently Asked Questions regarding the provision of methadone and buprenorphine for the treatment of Opioid Use Disorder for new and existing patients.

Sample OTP COVID-19 FAQs

This document is being provided by SAMHSA as a sample set of Frequently Asked Questions. These have been reviewed and cleared by SAMHSA. States and programs are encouraged to review for potential consideration and application to their individual circumstances.

Tips for Social Distancing, Quarantine, and Isolation during an Infectious Disease Outbreak

In the event of an infectious disease outbreak, local officials may require the public to take measures to limit and control the spread of the disease. This tip sheet provides information about social distancing, quarantine, and isolation.

Use of Telemedicine While Providing Medication Assisted Treatment (MAT)

Under the Ryan Haight Act of 2008, where controlled substances are prescribed by means of the Internet, the general requirement is that the prescribing Practitioner must have conducted at least one in-person medical evaluation of the patient. U.S.C. § 829(e). However, the Act provides an exception to this requirement. 21 U.S.C. § 829 (e)(3)(A).

TAP 34: Disaster Planning Handbook for Behavioral Health Treatment Programs

This handbook offers guidance in creating a disaster preparedness and recovery plan for programs that provide treatment for mental illness and substance use disorders. It describes the planning process, preparing for a disaster, roles and responsibilities, training, and testing.

COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance

In response to the Novel Coronavirus Disease (COVID-19) pandemic, SAMHSA is providing COVID-19 Public Health Emergency Response and 42 CFR Part 2 guidance to ensure that substance use disorder treatment services are uninterrupted during this public health emergency.

MEDICARE TELEMEDICINE HEALTH CARE PROVIDER FACT SHEET: Medicare Coverage and Payment of Virtual Services

Under President Trump’s leadership, the Centers for Medicare & Medicaid Services (CMS) has broadened access to Medicare telehealth services so that beneficiaries can receive a wider range of services from their doctors without having to travel to a healthcare facility. These policy changes build on the regulatory flexibilities granted under the President’s emergency declaration.

Notification of Enforcement Discretion on Telehealth Remote Communications

On March 17, the Office for Civil Rights (OCR) at the U.S Department of Health and Human Services announced, effective immediately, that it will exercise its enforcement discretion and will waive potential penalties for HIPAA violations against health care providers that serve patients through everyday communications technologies during the COVID-19 nationwide public health emergency. In support of this action, OCR is providing further guidance explaining how covered health care providers can use remote video communication products and offer telehealth to patients responsibly.

TIP 42: Substance Abuse Treatment for Persons with Co-Occurring Disorders

This updated (March 2020) TIP is intended to provide addiction counselors and other providers, supervisors, and administrators with the latest science in the screening, assessment, diagnosis, and management of co-occurring disorders.

Print Friendly, PDF & Email